tradingkey.logo

Neogenomics Inc

NEO
View Detailed Chart

6.580USD

-3.390-34.00%
Close 04/29, 16:00ETQuotes delayed by 15 min
843.20MMarket Cap
LossP/E TTM

Neogenomics Inc

6.580

-3.390-34.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-34.00%

5 Days

-32.51%

1 Month

0.00%

6 Months

0.00%

Year to Date

0.00%

1 Year

0.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 15 analysts
BUY
Current Rating
17.208
Target Price
72.60%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

67
Total
7
Median
8
Average
Company name
Ratings
Analysts
Neogenomics Inc
NEO
15
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
26
Teladoc Health Inc
TDOC
26
Privia Health Group Inc
PRVA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(2)
Neutral(0)
Buy(0)
Indicators
Sell(0)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
--
--
RSI(14)
--
--
STOCH(KDJ)(9,3,3)
--
--
ATR(14)
--
--
CCI(14)
--
--
Williams %R
--
--
TRIX(12,20)
--
--
StochRSI(14)
--
--
Moving Average
Sell(2)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
--
--
MA10
--
--
MA20
--
--
MA50
--
--
MA100
--
--
MA200
--
--

News

More news coming soon, stay tuned...

Company

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
Company codeNEO
CompanyNeogenomics Inc
CEOMr. Antony P. Zook
Websitehttps://neogenomics.com/